Citigroup’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-156,748
Closed -$3.27M 6199
2022
Q3
$3.27M Sell
156,748
-30,543
-16% -$636K ﹤0.01% 1800
2022
Q2
$3.89M Buy
187,291
+80,581
+76% +$1.43M ﹤0.01% 1678
2022
Q1
$1.79M Buy
106,710
+2,964
+3% +$51.8K ﹤0.01% 2458
2021
Q4
$2.07M Sell
103,746
-215,113
-67% -$4.05M ﹤0.01% 2595
2021
Q3
$5.78M Buy
318,859
+237,092
+290% +$5.44M ﹤0.01% 1718
2021
Q2
$2.21M Buy
81,767
+30,988
+61% +$867K ﹤0.01% 2595
2021
Q1
$1.52M Sell
50,779
-16,536
-25% -$564K ﹤0.01% 2680
2020
Q4
$1.94M Buy
67,315
+4,345
+7% +$117K ﹤0.01% 2886
2020
Q3
$1.54M Sell
62,970
-44,245
-41% -$954K ﹤0.01% 2902
2020
Q2
$1.92M Buy
107,215
+6,180
+6% +$81.2K ﹤0.01% 2855
2020
Q1
$822K Buy
101,035
+46,317
+85% +$529K ﹤0.01% 3387
2019
Q4
$722K Sell
54,718
-15,374
-22% -$186K ﹤0.01% 4079
2019
Q3
$833K Buy
70,092
+30,911
+79% +$572K ﹤0.01% 3847
2019
Q2
$959K Buy
39,181
+27,540
+237% +$793K ﹤0.01% 3681
2019
Q1
$370K Buy
+11,641
New +$413K ﹤0.01% 4505

Other funds holding CVET

Citigroup's CVET Position: Q4 2022 in Review

Citigroup sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 156,748 shares — an estimated $3.27M sold.

Citigroup first reported a position in CVET in Q1 2019 and held it in 15 quarters. The position peaked at $5.78M in Q3 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Citigroup reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Citigroup sold 156,748 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $3.27M.
  • Citigroup first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 15 quarters.
  • Citigroup's Covetrus, Inc. Common Stock position peaked at $5.78M in Q3 2021.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.